Literature DB >> 7994693

No stone left unturned at Montreal hospital's clinical research unit.

J Hamilton.   

Abstract

Mesh：

Year:  1994        PMID： 7994693      PMCID： PMC1337463     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  Rules of evidence and clinical recommendations on the use of antithrombotic agents.

Authors:  D J Cook; G H Guyatt; A Laupacis; D L Sackett
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

Review 2.  Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

3.  Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose.

Authors:  R A O'Reilly; P M Aggeler
Journal:  Circulation       Date:  1968-07       Impact factor: 29.690

4.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

5.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

6.  Anticoagulation in patients with atrial fibrillation. Atrial fibrillation associated with aging.

Authors:  T Lancaster
Journal:  BMJ       Date:  1993-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.